14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $141.16 $183.01 Friday, 3rd May 2024 AFMD stock ended at $5.42. This is 2.26% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 8.04% from a day low at $5.10 to a day high of $5.51.
90 days $141.16 $227.30
52 weeks $84.73 $227.30

Historical Affimed N.V. prices

Date Open High Low Close Volume
May 13, 2020 $21.50 $22.40 $20.10 $20.50 92 863
May 12, 2020 $22.20 $22.80 $21.35 $21.60 72 988
May 11, 2020 $22.60 $23.00 $22.10 $22.20 59 976
May 08, 2020 $22.00 $23.00 $22.00 $22.60 44 457
May 07, 2020 $22.70 $22.80 $21.30 $22.00 62 653
May 06, 2020 $21.20 $22.20 $20.60 $22.10 56 847
May 05, 2020 $20.50 $22.00 $20.50 $21.10 79 254
May 04, 2020 $19.50 $20.80 $19.10 $20.45 75 036
May 01, 2020 $21.20 $21.70 $19.90 $20.30 79 911
Apr 30, 2020 $21.70 $22.30 $21.10 $21.90 72 274
Apr 29, 2020 $23.30 $23.30 $21.30 $22.00 68 711
Apr 28, 2020 $23.90 $23.90 $21.30 $22.30 121 269
Apr 27, 2020 $22.60 $22.80 $21.80 $22.40 70 463
Apr 24, 2020 $21.70 $22.90 $21.50 $22.40 46 993
Apr 23, 2020 $22.30 $22.80 $21.55 $21.70 55 099
Apr 22, 2020 $22.50 $23.10 $21.80 $22.30 47 998
Apr 21, 2020 $21.80 $23.00 $21.70 $22.00 58 281
Apr 20, 2020 $23.00 $24.20 $21.90 $22.40 114 863
Apr 17, 2020 $22.20 $23.50 $21.60 $23.00 93 955
Apr 16, 2020 $21.70 $22.20 $20.90 $21.60 96 987
Apr 15, 2020 $21.40 $22.30 $20.10 $21.50 95 979
Apr 14, 2020 $21.40 $22.15 $20.50 $21.40 80 654
Apr 13, 2020 $19.90 $21.10 $19.20 $20.80 61 547
Apr 09, 2020 $19.80 $20.40 $19.00 $19.90 96 633
Apr 08, 2020 $18.30 $20.30 $17.80 $19.50 144 193
Click to get the best stock tips daily for free!

About Affimed N.V.

Affimed N.V. Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in Phase I clinical trial for hodgkin lymphoma. The company is also developing AFM24, a tetravalent, bispec... AFMD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT